Premium
Combined treatment approach to chronic anal fissure with associated anal fistula
Author(s) -
FitzDowse Andrew J.,
Behrenbruch Corina C.,
Hayes Ian P.
Publication year - 2017
Publication title -
anz journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 70
eISSN - 1445-2197
pISSN - 1445-1433
DOI - 10.1111/ans.14292
Subject(s) - fistulotomy , medicine , anal fistula , fistula , botulinum toxin , surgery , anal fissure
Background Anal fistula in association with chronic anal fissure (fissure‐fistula) is infrequently described. Recognizing this association and managing both components may help prevent some treatment failures seen with chronic anal fissure. This study aims to report on the outcomes of 20 consecutive patients with fissure‐fistula managed with fistulotomy and injection of botulinum A toxin. Methods The study is a retrospective, observational study, assessing the success of symptom resolution following fistulotomy with botulinum A toxin, in patients identified as having a chronic anal fissure with associated anal fistula. The study included all patients with this condition treated with combination treatment by a single surgeon at a tertiary care hospital between January 2013 and January 2016. Results Twenty patients with fissure‐fistula treated with fistulotomy and botulinum toxin A were identified. The median cohort age was 44 years (range 25–78), with a predominance of males (80%) and posterior fissure position (80%). The most common presenting symptoms were anal pain (70%), rectal bleeding (55%), anal discharge (35%) and anal pruritus (35%). Mean follow‐up was 10.5 weeks and all patients who attended follow‐up appointments reported resolution of symptoms. There were no cases of incontinence and none of the cohort required further surgical intervention for the condition. Conclusion Chronic anal fissure with associated anal fistula can be successfully managed with fistulotomy and injection of botulinum toxin A. Further studies would be helpful in determining if recognition and management of the fistula component in isolation with fistulotomy is as effective as fistulotomy plus botulinum A toxin.